Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
Open Access
- 26 June 2021
- journal article
- research article
- Published by Elsevier in Journal of Advanced Research
- Vol. 37, 235-253
Abstract
No abstract availableKeywords
Funding Information
- University of Limerick
This publication has 263 references indexed in Scilit:
- miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasisNature Cell Biology, 2013
- GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expressionNature Cell Biology, 2013
- Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancerEuropean Journal of Human Genetics, 2012
- MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiformeCell Death & Disease, 2012
- miR-205 regulates basement membrane deposition in human prostate: implications for cancer developmentCell Death & Differentiation, 2012
- Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10bJournal of Biological Chemistry, 2011
- MiR-148a inhibits angiogenesis by targeting ERBB3Journal of Biomedical Research, 2011
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisNature Cell Biology, 2010
- Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and AktInternational Journal of Cancer, 2009
- CXCL8/IL‐8 and CXCL12/SDF‐1α co‐operatively promote invasiveness and angiogenesis in pancreatic cancerInternational Journal of Cancer, 2008